This Journal of Hematology & Oncology series calls for clinical studies on novel agents for cancers and blood disorders. Summaries and reviews on first-in-human or first-in-class studies are also welcome.
Submissions should be made through the journal's Editorial Manager system. The deadline for submissions is 31 October 2021.
First-in-human clinical trials for cancer and blood disorders
There are currently no articles in this collection.
